- Report
- October 2025
- 198 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- December 2025
- 762 Pages
Global
From €5116EUR$5,800USD£4,494GBP
- Report
- January 2025
- 343 Pages
Global
From €4233EUR$4,799USD£3,719GBP
- Report
- September 2025
- 450 Pages
Global
From €4366EUR$4,950USD£3,836GBP
- Report
- December 2025
- 269 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- June 2025
- 180 Pages
Global
From €5248EUR$5,950USD£4,611GBP
- Report
- May 2025
- 100 Pages
Global
From €5248EUR$5,950USD£4,611GBP
- Report
- November 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 191 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- October 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 192 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 181 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- October 2025
- 164 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- May 2025
- 115 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- May 2025
- 159 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- May 2025
- 120 Pages
Global
From €4190EUR$4,750USD£3,681GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP

The COVID 19 Vaccine market is a rapidly growing sector of the Vaccines industry. It is driven by the urgent need to develop a safe and effective vaccine to protect against the novel coronavirus. Companies in the market are working to develop and manufacture vaccines that can be used to protect people from the virus. Vaccines are being developed using a variety of technologies, including mRNA, DNA, and viral vector-based approaches.
The COVID 19 Vaccine market is highly competitive, with many companies vying for a share of the market. Companies are investing heavily in research and development to develop vaccines that are safe and effective. They are also investing in manufacturing and distribution capabilities to ensure that the vaccines can be quickly and efficiently delivered to those who need them.
Some of the companies in the COVID 19 Vaccine market include Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi. These companies are working to develop and manufacture vaccines that can be used to protect people from the virus. Show Less Read more